A total of 17 products were added in the month from four different asset managers: WisdomTree, T. Rowe Price, Invesco, Capital Four, Equitix and Madison Realty Capital.
CCR Monthly Approval Report – February 2023
A total of five products were added in the month from five different asset managers: AllianceBernstein, Credicorp Capital, HIG Capital, Q-Energy and TA Associates.
CCR Monthly Approval Report – January 2023
Two ETFs, two mutual funds and one alternatives product gained CCR approval to kick off 2023. Sponsors gaining approval were Barings, GemCap, BNP Paribas, UBS and GlP.
CCR Monthly Approval Report – December 2022
Ninety One and America Securities were the fund sponsors gaining approval for new products in December.
CCR changes criteria and reinstates Allianz funds
In October 2022, Allianz was authorized to distribute 26 strategies to Chilean pension funds.
CCR Monthly Approval Report – November 2022
A total of five products were added in the month from the following asset managers: Eastspring, Jupiter, Neuberger Berman, UBS and Stonepeak Partners.
CCR Monthly Approval Report – October 2022
A total of 35 products were added in the month from seven different asset managers: Aegon, Allianz, BNP Paribas, The Colchester, Bridge, Driftwood and Vitruvian.
CCR Monthly Approval Report – September 2022
UBS, Altor and Cortland were the fund sponsors gaining approval for new products in September.
CCR Monthly Approval Report – August 2022
A total of 15 products were added in the month from six different brands: Actis, Amundi, Brookfield, Global X, M&G, and Mirae.